慢性疾患管理市場：疾患タイプ、製品タイプ、エンドユーザー、ケアタイプ、デリバリーモード別-2025-2030年世界予測

慢性疾患管理市場は、2023年に93億3,000万米ドルと評価され、2024年には101億2,000万米ドルに達すると予測され、CAGR 7.10％で成長し、2030年には150億9,000万米ドルに達すると予測されています。

慢性疾患管理（CDM）には、糖尿病、心血管疾患、喘息などの長期にわたる非伝染性疾患に苦しむ患者の幸福を管理し改善するために考案された、包括的で継続的なケアと戦略が含まれます。CDMの必要性は、人口の高齢化、座りがちなライフスタイル、不健康な食生活によって慢性疾患が世界的に蔓延していることから生じています。CDMの用途は、遠隔医療サービス、患者教育、生活習慣指導、効果的な治療アドヒアランスの確保、入院の削減、生活の質の向上を目的とした投薬管理など多岐にわたる。最終用途の主な部門には、病院、クリニック、患者中心の組織、在宅医療などがあり、ケアの効率を高めるためにCDMソリューションの採用が増えています。

この市場の成長に影響を与える主な要因には、健康モニタリング機器の技術的進歩、遠隔医療の採用増加、患者の治療計画における予測分析のための人工知能（AI）の統合などがあります。遠隔モニタリングとデータ分析を提供するウェアラブル技術とモバイルヘルスアプリに存在する最新の機会は、患者のエンゲージメントと処方された治療法のアドヒアランスを大幅に向上させる。企業は、リアルタイムの健康追跡と個別ケアのためにAIとIoTを統合した患者中心のプラットフォームのイノベーションを促進することによって、これらの機会を活用すべきです。

しかし、データ・プライバシーへの懸念、ヘルスケアITシステム間の限られた相互運用性、新興の医療技術に精通した熟練した専門家の不足といった課題が残っています。特に低所得地域では、経済格差がCDMソリューションへのアクセスに影響し、市場浸透を妨げています。企業は、患者データのセキュリティを優先した安全で相互運用可能なシステムの構築に注力する一方、十分なサービスを受けていない市場へのアクセスを拡大する政策を提唱する必要があります。

成長とイノベーションを促進するために、企業はAIを活用した予測分析、安全なデータ共有のためのブロックチェーン、低コストで拡張性のあるデジタルヘルスプラットフォームの開発などの道を探ることができます。CDM市場は、バリューベースのケアモデルに軸足を置く、ダイナミックで成長志向の市場であり、慢性疾患管理の全体的な効率性と有効性の向上を目指しています。

市場力学：急速に進化する慢性疾患管理市場の主要市場インサイトを公開

慢性疾患管理市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の世界の蔓延による、効果的な管理ソリューションへの需要の高まり
  • ヘルスケア技術の進歩による慢性疾患のモニタリングと管理能力の向上
  • 慢性疾患管理の重要性に対するヘルスケアプロバイダーや患者の意識の高まり
  • 慢性疾患管理に焦点を当てた革新的なヘルスケア提供モデルによる患者の転帰と経験の改善
• 市場抑制要因
  • 高度な治療、技術、長期ケアに伴う高コスト
  • データ漏洩、不正アクセス、機密性の高い患者情報の損失に対する懸念
• 市場機会
  • 十分なサービスを受けていないコミュニティにおける慢性疾患管理に対応するモバイルヘルスプラットフォームの拡大
  • 慢性疾患管理への人工知能の統合による個別化治療計画の実現
  • 慢性疾患患者の再入院を減らすための遠隔モニタリングソリューションの開発
• 市場の課題
  • 様々なヘルスケアプロバイダー、専門家、介護者間の連携不足による一貫性のないケアとコミュニケーションギャップ
  • 患者が処方された治療計画を確実に守ることの難しさ

ポーターの5つの力：慢性疾患管理市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：慢性疾患管理市場における外部からの影響の把握

外部マクロ環境要因は、慢性疾患管理市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析慢性疾患管理市場における競合情勢の把握

慢性疾患管理市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス慢性疾患管理市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、慢性疾患管理市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨慢性疾患管理市場における成功への道筋を描く

慢性疾患管理市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延が世界的に増加し、効果的な管理ソリューションの需要が高まっています。
    • 慢性疾患のモニタリングと管理能力を強化するヘルスケア技術の進歩
    • ヘルスケア従事者と患者の間で慢性疾患管理の重要性についての認識が高まっている
    • 患者の転帰と体験を改善することに重点を置いた革新的なヘルスケア提供モデル
  • 抑制要因
    • 高度な治療、技術、長期ケアに伴う高額な費用
    • データ漏洩、不正アクセス、患者の機密情報の紛失に対する懸念
  • 機会
    • 十分なサービスを受けていないコミュニティの慢性疾患管理に対応するモバイルヘルスプラットフォームの拡大
    • 慢性疾患管理に人工知能を統合することで、パーソナライズされた治療計画が可能になります
    • 慢性疾患患者の再入院を減らすための遠隔モニタリングソリューションの開発
  • 課題
    • さまざまなヘルスケア提供者、専門家、介護者間の連携の欠如により、一貫性のないケアやコミュニケーションのギャップが生じる
    • 患者が処方された治療計画を順守することを保証するのが難しい
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 慢性疾患管理市場：疾患タイプ別

• がん
• 心血管疾患
• 慢性腎臓病
• 慢性呼吸器疾患
• 糖尿病

第7章 慢性疾患管理市場：製品タイプ別

• デバイス
  • 診断装置
  • 監視デバイス
  • 治療機器
• 薬物
  • 鎮痛剤
  • 降圧剤
  • 気管支拡張薬
  • インスリン
• サービス
  • 在宅ヘルスケア
  • 遠隔医療

第8章 慢性疾患管理市場：エンドユーザー別

• クリニック
• ホームケア設定
• 病院
• 長期ケアセンター

第9章 慢性疾患管理市場ケアタイプ別

• プロフェッショナルケア
• 自己治療

第10章 慢性疾患管理市場配送方法別

• クラウドベース
• オンプレミス

第11章 南北アメリカの慢性疾患管理市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の慢性疾患管理市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの慢性疾患管理市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Abbott Laboratories
• 2. AstraZeneca plc
• 3. Boehringer Ingelheim GmbH
• 4. DexCom, Inc.
• 5. Eli Lilly and Company
• 6. Glooko, Inc.
• 7. Health Catalyst Inc.
• 8. Hinge Health, Inc.
• 9. Lark Technologies, Inc.
• 10. Livongo Health, Inc.
• 11. Medtronic plc
• 12. Merck & Co., Inc.
• 13. MySugr GmbH
• 14. Novo Nordisk A/S
• 15. Omada Health, Inc.
• 16. Propeller Health
• 17. Roche Holding AG
• 18. Sanofi S.A.
• 19. Virta Health Corp.
• 20. Welldoc, Inc.

LIST OF FIGURES

• FIGURE 1. CHRONIC DISEASE MANAGEMENT MARKET RESEARCH PROCESS
• FIGURE 2. CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CHRONIC DISEASE MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CHRONIC DISEASE MANAGEMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CHRONIC DISEASE MANAGEMENT MARKET DYNAMICS
• TABLE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PROFESSIONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SELF-CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 65. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 69. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 70. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 107. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 110. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 111. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 115. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 119. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 120. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 144. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 148. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 152. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 160. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 172. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 176. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 178. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 180. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 192. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 205. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 211. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 213. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 217. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 219. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 225. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 227. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 233. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 235. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 237. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 241. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 243. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 245. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 249. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 250. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 251. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 252. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 253. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 255. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 256. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 257. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 258. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 259. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 261. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 265. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 267. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 269. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 273. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 275. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 281. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 282. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 283. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 284. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 285. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 286. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 287. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 288. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 289. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 291. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 292. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 293. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 294. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 295. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 296. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 297. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 298. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 299. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 300. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 301. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 302. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 304. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 305. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 306. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 307. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 308. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 310. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 312. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 314. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 316. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 317. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 318. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 320. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 322. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 324. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 325. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 326. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 327. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 328. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 329. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 330. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
• TABLE 331. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
• TABLE 332. SWEDEN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)

TABLE 333.

The Chronic Disease Management Market was valued at USD 9.33 billion in 2023, expected to reach USD 10.12 billion in 2024, and is projected to grow at a CAGR of 7.10%, to USD 15.09 billion by 2030.

Chronic Disease Management (CDM) involves comprehensive, continuous care and strategies designed to manage and improve patients' well-being suffering from long-lasting, non-communicable ailments such as diabetes, cardiovascular disease, and asthma. The necessity of CDM arises from the growing global prevalence of chronic diseases fueled by aging populations, sedentary lifestyles, and unhealthy diets. Its applications span telehealth services, patient education, lifestyle coaching, and medication management to ensure effective treatment adherence, reduce hospitalizations, and improve life quality. End-use sectors primarily include hospitals, clinics, patient-centric organizations, and home healthcare, increasingly adopting CDM solutions to enhance care efficiency.

Key factors influencing this market's growth include technological advancements in health monitoring devices, the rising adoption of telemedicine, and the integration of Artificial Intelligence (AI) for predictive analytics in patient treatment plans. Latest opportunities present in wearable technology and mobile health apps, which offer remote monitoring and data analytics, significantly improve patient engagement and adherence to prescribed therapies. Businesses should leverage these opportunities by fostering innovations in patient-centric platforms that integrate AI and IoT for real-time health tracking and personalized care.

However, challenges persist in data privacy concerns, limited interoperability between healthcare IT systems, and a lack of skilled professionals adept in emerging health technologies. Economic disparities impact access to CDM solutions, particularly in low-income regions, hindering market penetration. Companies must focus on building secure, interoperable systems that prioritize patient data security while advocating for policies that expand access to underserved markets.

To spur growth and innovation, businesses can explore avenues in AI-driven predictive analytics, blockchain for secure data sharing, and the development of low-cost, scalable digital health platforms. The CDM market represents a dynamic, growth-oriented landscape pivoting towards value-based care models, aiming to enhance the overall efficiency and efficacy of chronic disease management.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Disease Management Market

The Chronic Disease Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
  • Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
  • Growing awareness among healthcare providers and patients about the importance of chronic disease management
  • Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
• Market Restraints
  • High cost associated with advanced treatments, technologies, and long-term care
  • Concerns over data breaches, unauthorized access, and loss of sensitive patient information
• Market Opportunities
  • Expansion of mobile health platforms addressing chronic disease management in underserved communities
  • Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
  • Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
• Market Challenges
  • Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
  • Difficulties in ensuring patients adherence to their prescribed treatment plans

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Disease Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Disease Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Disease Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Disease Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Disease Management Market

A detailed market share analysis in the Chronic Disease Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Disease Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Disease Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Disease Management Market

A strategic analysis of the Chronic Disease Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Disease Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, Glooko, Inc., Health Catalyst Inc., Hinge Health, Inc., Lark Technologies, Inc., Livongo Health, Inc., Medtronic plc, Merck & Co., Inc., MySugr GmbH, Novo Nordisk A/S, Omada Health, Inc., Propeller Health, Roche Holding AG, Sanofi S.A., Virta Health Corp., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Chronic Disease Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Type, market is studied across Cancer, Cardiovascular Diseases, Chronic Kidney Diseases, Chronic Respiratory Diseases, and Diabetes.
• Based on Product Type, market is studied across Devices, Drugs, and Services. The Devices is further studied across Diagnostic Devices, Monitoring Devices, and Therapeutic Devices. The Drugs is further studied across Analgesics, Antihypertensive, Bronchodilators, and Insulin. The Services is further studied across Home Healthcare and Telemedicine.
• Based on End User, market is studied across Clinics, Homecare Settings, Hospitals, and Long-term Care Centers.
• Based on Care Type, market is studied across Professional Care and Self-care.
• Based on Delivery Mode, market is studied across Cloud-based and On-premise.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
    • 5.1.1.2. Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
    • 5.1.1.3. Growing awareness among healthcare providers and patients about the importance of chronic disease management
    • 5.1.1.4. Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with advanced treatments, technologies, and long-term care
    • 5.1.2.2. Concerns over data breaches, unauthorized access, and loss of sensitive patient information
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of mobile health platforms addressing chronic disease management in underserved communities
    • 5.1.3.2. Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
    • 5.1.3.3. Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
    • 5.1.4.2. Difficulties in ensuring patients adherence to their prescribed treatment plans
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Chronic Disease Management Market, by Disease Type

• 6.1. Introduction
• 6.2. Cancer
• 6.3. Cardiovascular Diseases
• 6.4. Chronic Kidney Diseases
• 6.5. Chronic Respiratory Diseases
• 6.6. Diabetes

7. Chronic Disease Management Market, by Product Type

• 7.1. Introduction
• 7.2. Devices
  • 7.2.1. Diagnostic Devices
  • 7.2.2. Monitoring Devices
  • 7.2.3. Therapeutic Devices
• 7.3. Drugs
  • 7.3.1. Analgesics
  • 7.3.2. Antihypertensive
  • 7.3.3. Bronchodilators
  • 7.3.4. Insulin
• 7.4. Services
  • 7.4.1. Home Healthcare
  • 7.4.2. Telemedicine

8. Chronic Disease Management Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Homecare Settings
• 8.4. Hospitals
• 8.5. Long-term Care Centers

9. Chronic Disease Management Market, by Care Type

• 9.1. Introduction
• 9.2. Professional Care
• 9.3. Self-care

10. Chronic Disease Management Market, by Delivery Mode

• 10.1. Introduction
• 10.2. Cloud-based
• 10.3. On-premise

11. Americas Chronic Disease Management Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Chronic Disease Management Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Chronic Disease Management Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca plc
• 3. Boehringer Ingelheim GmbH
• 4. DexCom, Inc.
• 5. Eli Lilly and Company
• 6. Glooko, Inc.
• 7. Health Catalyst Inc.
• 8. Hinge Health, Inc.
• 9. Lark Technologies, Inc.
• 10. Livongo Health, Inc.
• 11. Medtronic plc
• 12. Merck & Co., Inc.
• 13. MySugr GmbH
• 14. Novo Nordisk A/S
• 15. Omada Health, Inc.
• 16. Propeller Health
• 17. Roche Holding AG
• 18. Sanofi S.A.
• 19. Virta Health Corp.
• 20. Welldoc, Inc.